Rechallenging with immune checkpoint inhibition after a treatment-limiting immune-related adverse event.
Year: 2020
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: University of Kentucky, Markey Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3032739665
